Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASAP: Perioperative Aspirin in Resectable Pancreatic Head Cancer
NCT05637567Phase 2Not yet recruiting
- Sponsor
- German Cancer Research Center
- Start
- Apr 2024
- Primary completion
- Sep 2028
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of aspirin in pancreatic ductal adenocarcinoma (PDAC), sponsored by German Cancer Research Center. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
aspirin
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT05637567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05637567.